U.S. Electrical Stock News

Biglari Holdings (BH.A) has wrapped up FY 2025 with fourth quarter revenue of US$99.9 million and a basic EPS loss of US$193.44, while trailing twelve month revenue came in at US$395.3 million alongside a basic EPS loss of US$143.86. Over recent quarters the company has seen revenue move from US$91.1 million in Q4 2024 to around US$100.6 million at its Q2 2025 peak. EPS has swung between a gain of US$194.57 and losses including US$37.56 and US$126.40, setting up a choppy earnings profile that...

What TWFG’s Recent Share Moves Signal for Investors TWFG (TWFG) has drawn investor attention after recent share price moves, with the stock showing mixed short term performance, modest gains over the past month, but a sharper decline over the past 3 months and year. See our latest analysis for TWFG. At a share price of $19.35, TWFG’s recent 1 day and 7 day share price returns have been positive, but the 90 day share price return and 1 year total shareholder return both point to fading...

If you are wondering whether Helmerich & Payne at around US$36.90 is still offering value after a strong run, this breakdown will help you see how the current price stacks up against several valuation checks. The stock has had a mixed short term, with an 8.6% decline over the last 7 days, a 2.8% gain over the past 30 days, and returns of 23.2% year to date and 110.2% over the last year. Recent coverage has focused on Helmerich & Payne in the context of ongoing interest in energy services...

MSA Safety (NYSE:MSA) has signed a definitive agreement to acquire Norway based Autronica Fire & Security. The deal values Autronica at about $550–$555 million. The acquisition adds depth in fire and gas detection for petrochemical, oil and gas, maritime, and wider industrial markets. For investors tracking NYSE:MSA, this move comes with the stock around $171.9 and a value score of 4, alongside a 10.5% return over the past year and 25.6% over three years. The company has also posted a 6.0%...

Virtu Financial (NYSE:VIRT) has joined zerohash's liquidity ecosystem as a market-making partner. The company is providing liquidity across zerohash's central limit order book and request for quote systems. The move connects Virtu's market-making capabilities with a growing digital asset infrastructure provider. For you as an investor, this move ties a traditional electronic market maker directly into a digital asset venue. Virtu Financial focuses on market making and trade execution across...

If you are wondering whether F&G Annuities & Life is attractively priced or just looks cheap on the surface, its recent share performance gives a few clues worth unpacking. The stock last closed at US$27.08, with a 10.1% gain over the past month but a 9.0% decline over the last year and a 9.9% decline year to date, which may leave you questioning whether sentiment or fundamentals are in the driving seat. Recent coverage of F&G Annuities & Life has focused on its position as a listed insurer...

Plains GP Holdings FY 2025 earnings recap Plains GP Holdings (PAGP) has just wrapped up FY 2025 with fourth quarter revenue of US$10.6 billion and a basic EPS loss of US$0.20, as investors weigh these headline figures against a current share price of US$23.63. Over recent quarters the company has seen revenue move between US$10.6 billion and US$12.5 billion. Basic EPS has ranged from a loss of US$0.44 in late 2024 to a small profit of US$0.04 in Q3 2025. This sets the stage for a close look...

If you are wondering whether Amdocs stock is starting to look like value or a value trap, the current share price puts that question front and center. The stock closed at US$65.14 recently, with returns of 0.7% over 7 days, a 1.9% decline over 30 days, an 18.7% decline year to date and a 27.6% decline over the last year. This naturally raises questions about how the market is reassessing both growth potential and risk. Recent coverage has focused on how Amdocs fits into broader shifts in...

Wondering if Adecoagro's recent share price puts it at a bargain or already reflects its strengths? This article breaks down what the current valuation is really telling you. The stock last closed at US$13.37, with a 72.3% return year to date and a 59.0% return over the past year. This is set against shorter term pullbacks of 5.1% over 7 days and 11.0% over 30 days that may signal shifting sentiment around risk and reward. Recent news around global food supply resilience, agricultural input...

Hawaiian Electric Industries (HE) has reported fourth quarter FY 2025 revenue of US$805.8 million and basic EPS of US$0.23, rounding out a trailing twelve month EPS of US$0.71 on revenue of about US$3.1 billion. The company has seen quarterly revenue move from US$799.2 million and EPS of US$0.17 in Q4 2024 to US$805.8 million and EPS of US$0.23 in Q4 2025. Over the same period, the trailing twelve month line has shifted from revenue of US$3.2 billion and EPS of a US$10.42 loss in Q4 2024 to...

If you are wondering whether MaxLinear's recent share price move has left the stock looking expensive or still potentially interesting, the valuation story is where your attention should be. The stock last closed at US$82.37, with returns of 16.4% over 7 days, 347.4% over 30 days, 345.0% year to date and a very large 1 year gain that is more than 6x. These moves sit against a backdrop of ongoing interest in semiconductor stocks, with investors watching closely for updates on demand for...

Alamar Biosciences (NasdaqGS:ALMR) doubled its revenue in Q1 2026. The company launched two new products aimed at neurodegenerative disease research. Alamar completed an IPO in 2026 to support its next phase of growth. Alamar Biosciences operates in the life sciences tools and diagnostics space, where demand for more precise protein and biomarker measurement has been a key theme for researchers and drug developers. The new products focused on neurodegenerative disease research sit in an...

Why the upcoming TN-401 data matters for Tenaya Therapeutics stock Tenaya Therapeutics (TNYA) is drawing attention as investors look ahead to new clinical safety and efficacy data for TN-401, its gene therapy for PKP2-associated arrhythmogenic right ventricular cardiomyopathy, at the ASGCT 2026 meeting. This late breaking oral presentation, together with additional abstracts on Tenaya’s gene therapy and gene editing programs, gives you fresh information to evaluate the company’s pipeline...

AdvanSix (ASIX) closed out FY 2025 with Q4 revenue of US$359.9 million and a basic EPS loss of US$0.10. The trailing twelve months show EPS of US$1.83 on revenue of about US$1.5 billion. Over recent periods, revenue has moved from US$329.1 million in Q4 2024 to US$410.0 million in Q2 2025. Quarterly EPS has ranged from a small profit of US$0.01 in Q4 2024 to a high of US$1.17 in Q2 2025, giving investors a mix of profitable quarters and losses at the year end. With net profit margin at 3.2%...

AGI (NYSE:AGBK) has filed a substantial Shelf Registration tied to an Employee Stock Ownership Plan for a large block of Class A common shares. The filing outlines a framework for issuing ESOP related shares over time, which can influence the company’s capital structure and employee ownership levels. AGI, trading at $7.39, has had mixed recent performance, with the stock up 4.2% over the past week and 9.5% over the past month, while showing a 31.3% decline year to date. The new ESOP related...

Zai Lab (NasdaqGM:ZLAB) reported new clinical data from its global oncology and immunology pipeline, including intracranial response data for zoci in small cell lung cancer. The company is preparing to launch KarXT in China for schizophrenia in the next quarter. Management highlighted these pipeline and launch updates while also flagging near term revenue pressure. Zai Lab focuses on developing and commercializing medicines in oncology and immunology, as well as central nervous system...

Digi International acquired Jolt Software and Particle Industries, reshaping its Internet of Things (IoT) offering. The company reports that these deals, combined with organic growth, have lifted annual recurring revenue (ARR) by 50%. Management highlights strong cash flow as a key support for integrating these acquisitions into the existing business. Digi International (NasdaqGS:DGII) is drawing fresh attention as it leans harder into IoT platforms and recurring software revenue. The stock...

Main Street Capital (MAIN) has wrapped up FY 2025 with fourth quarter revenue of US$145.5 million and basic EPS of US$1.46. This sets the tone for a year in which trailing twelve month revenue reached US$566.4 million and EPS was US$5.52. Over recent periods, the company has reported quarterly revenue ranging between US$137.0 million and US$145.5 million, while basic EPS has moved between US$1.31 and US$1.46. Trailing net income for the year was US$493.4 million, as investors weigh those...

NI Holdings (NODK) just closed out FY 2025 with Q4 total revenue of US$61.0 million and a basic EPS loss of US$0.15, alongside a net loss of US$3.2 million, putting margins firmly under pressure. Over recent quarters, total revenue has moved from US$73.9 million in Q4 2024 to US$71.4 million in Q1 2025 and US$76.1 million in Q2 2025 before landing at US$61.0 million in Q4 2025, while EPS has swung from a profit of US$0.47 in Q4 2024 to a loss of US$0.57 in Q2 2025 and a loss of US$0.15 in the...

Sharplink (NasdaqCM:SBET) has wrapped up FY 2025 with Q4 revenue of US$15.8 million and basic EPS of a US$3.51 loss, against a backdrop of trailing twelve month revenue of US$28.1 million and basic EPS of a US$7.37 loss. Over recent quarters, the company has seen quarterly revenue move from US$0.7 million in Q1 2025 to US$10.8 million in Q3 2025 and then US$15.8 million in Q4 2025, while EPS shifted from a US$1.73 loss in Q1 to EPS of US$0.70 in Q3 and back to a US$3.51 loss in Q4. This puts...

Esperion Therapeutics (ESPR) closed out FY 2025 with fourth quarter revenue of US$168.4 million and basic EPS of US$0.26, alongside trailing twelve month revenue of US$403.1 million and a basic EPS loss of US$0.11. Over recent quarters the company has seen revenue move from US$69.1 million in Q4 2024 to US$168.4 million in Q4 2025, while quarterly EPS shifted from a loss of US$0.11 in Q4 2024 to EPS of US$0.26 in Q4 2025. This sets up a results season in which investors will be weighing how...

If you are wondering whether Gilat Satellite Networks at around US$18.84 is priced for opportunity or disappointment, the starting point is to understand what the current valuation is really implying. The stock has posted returns of 2.1% over the last 7 days and 2.2% over the last 30 days, with year to date returns of 40.5% and a 1 year return of 189.0%, alongside a 3 year return of 243.2% and a 5 year return of 119.8%. Recent news flow around Gilat Satellite Networks has focused on its...

Wondering if Aptiv's current share price reflects its true worth, or if the recent swings are masking a clearer story about value. Aptiv closed at US$57.11, with returns of a 5.2% decline over 7 days, a 1.9% decline over 30 days, a 27.2% decline year to date, but a 10.3% gain over the past year, which can leave the stock looking quite different depending on the time frame you focus on. Those mixed returns sit against a backdrop of ongoing attention on Aptiv as an auto components supplier, as...

Geospace Technologies (GEOS) opened Q1 2026 with revenue of US$25.6 million and a basic EPS loss of US$0.76, alongside a trailing twelve month basic EPS loss of US$2.17 on revenue of US$99.2 million. Over recent quarters the company has reported revenue between US$18.0 million and US$37.2 million, while EPS has ranged from a profit of US$0.66 per share in Q1 2025 to several loss-making quarters since. For investors, that mix of fluctuating topline and persistent losses keeps the attention on...